A Multi-Center Screening Study to Characterize the Prevalence of the KIT D816V Mutation in Patients with Suspected Clonal Mast Cell Disease
- Sponsor:
- Blueprint Medicines Corporation
- Sponsor Study ID:
- BLU-MCAD-1101
- CTO #:
- 104221
- NCT Number:
- NCT07143669
- Phase:
- IV
- Protocol Type:
- Screening
- Age Group:
- Adults
- Disease Sites:
- Other Hematopoietic
- Study Objectives:
- Characterize the prevalence of the KIT D816V mutation in PB samples from participants with SMAC.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Coltoff, Alexander, at coltoff@musc.edu .
- Study Coordinator, Ward, Sarah, at saw306@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina